Anti-allergic effect of Petasites japonicus fermented with lactic acid bacteria in mice

Food and Agricultural Immunology

Volumn 20, Issue 2, 2009, Pages 155-164

  Bae, Eun Ah ^a   Trinh, Hien Trung ^a   Jang, Yun Ah ^b   Yun, Hyung Kwon ^b   Hong, Seong Sig ^b   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b National Institute of Animal Science   (South Korea)

Author keywords

Fermentation; Itching; Lactic acid bacteria; Passive cutaneous anaphylaxis reaction; Petasites japonicus

Indexed keywords

ASTERACEAE; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BREVE; LACTOBACILLUS ACIDOPHILUS; MUS; PETASITES; PETASITES JAPONICUS;

EID: 70449440394     PISSN: 09540105     EISSN: 14653443     Source Type: Journal    
DOI: 10.1080/09540100902974019     Document Type: Article

References (25)

1. Bae, E.A., Kim, N.Y., Han, M.J., Choo, M.K., & Kim, D.H. (2000). Transformation of ginsenosides to compound K by lactic acid bacteria of human intestine. Journal of Microbiology and Biotechnology, 13, 9-14.
2. Bielory, L. (2004). Complementary and alternative interventions in asthma, allergy, and immunology. Annuals of Allergy and Asthma Immunology, 93(2 Suppl. 1), S45-S54.
3. Choo, M.K., Park, E.K., Han, M.J., & Kim, D.H. (2003). Antiallergic activity of ginseng and its ginsenoside. Planta Medica, 69, 518-522.
4. Cui, H.S., Kim, M.R., & Sok, D.E. (2005). Protection by petaslignolide A, a major neuroprotective compound in the butanol extract of Petasites japonicus leaves, against oxidative damage in the brains of mice challenged with kainic acid. Journal of Agricultural Food Chemistry, 53, 8526-8532.
5. Friedman, E.S., La Natra, N., & Stiller, M.J. (2002). NSAIDs in dermatologic therapy: Review and preview. Journal of Cutaneous Medicine and Surgery, 6, 449-459.
6. Furumoto, Y., Nunomura, S., Terada, T., Rivera, J., & Ra, C. (2004). The FcepsilonRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. Journal of Biological Chemistry, 279, 49177-49187.
7. Ito, H., Miyazaki, T., Ono, M., & Sakurai, H. (1998). Antiallergic activities of rabdosiin and its related compounds: Chemical and biochemical evolutions. Bioorganic and Medicinal Chemistry, 6, 1051-1056.
8. Jiang, J.S., Shih, C.M., Wang, S.H., Chen, T.T., Lin, C.N., & Ko, W.C. (2006). Mechanisms of suppression of nitric oxide production by 3-O-methylquercetin in RAW 264.7 cells. Journal of Ethnopharmacology, 2103, 281-287.
9. Kempuraj, D., Huang, M., Kandere-Grzybowska, K., Basu, S., Boucher, W., Letourneau, R., et al. (2003). Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells. International Archives of Allergy and Immunology, 132, 231-239.
10. Leung, D.Y. (1995). Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. International Archives of Allergy Immunology, 96, 302-318.
11. Matsubara, K., Mori, M., & Mizushina, Y. (2004). Petasiphenol which inhibits DNA polymerase lambda activity is an inhibitor of in vitro angiogenesis. Oncology Report, 11, 447-451.
12. Matsuda, H., Morikawa, T., Ueda, K., Managi, H., & Yoshikawa, M. (2002). Structural requirement of flavonoids for inhibition of antigen-induced degranulation, TNF-a and IL-4 production from RBL-2H3 cells. Bioorganic and Medicinal Chemistry, 10, 2123-2128.
13. Min, B.S., Cui, H.S., Lee, H.K., Sok, D.E., & Kim, M.R. (2005). A new furofuran lignan with antioxidant and antiseizure activities from the leaves of Petasites japonicus. Archives of Pharmacal Research, 28, 1023-1026.
14. Mizushina, T., Ishidoh, T., Kamisuki, S., Nakazawa, S., Takemura, M., Sugawara, F., et al. (2003). Flavonoid glycoside: A new inhibitor of eukaryotic DNA polymerase alpha and a new carrier for inhibitor-affinity chromatography. Biochemical and Biophysical Research Communication, 301, 480-487.
15. Nyman, M. (1995). Effects of processing on dietary fibre in vegetables. European Journal of Clinical Nutrition, 49(Suppl. 3), S215-S218.
16. Sakuma, S., Higashi, Y., Sato, N., Sasakawa, T., Sengoku, T., Ohkubo, Y., et al. (2001). Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system (Comparison with steroids). International Immuno-pharmacology, 1, 1219-1226.
17. Schafer-Korting, M., Schmid, M.H., & Korting, H.C. (1996). Topical glucocorticoids with improved risk-benefit ratio. Drug Safety, 14, 375-385.
18. Shin, Y.W., Bae, E.A., Kim, S.S., Lee, Y.C., & Kim, D.H. (2005). Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. International Immuno-pharmacology, 5, 1183-1191.
19. Simons, F.E.R. (1992). The antiallergic effects of antihistamines (H1-receptor antagonists). Journal of Allergy and Clinical Immunology, 90, 705-715.
20. Steinkraus, K.H. (1983). Lactic acid fermentation in the production of foods from vegetables, cereals and legumes. Antonie Van Leeuwenhoek, 49, 337-348.
21. Stevens, R.L., & Austen, K.F. (1989). Recent advances in the cellular and molecular biology of mast cells. Immunology Today, 10, 381-386.
22. Sugimoto, Y., Umakoshi, K., Nojiri, N., & Kamei, C. (1998). Effect of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. European Journal of Pharmacology, 351, 1-5.
23. Tobinaga, S., Takeuchi, N., Kasama, T., Yamashita, J., Aida, Y., & Kaneko, Y. (1983). Anti- histaminic and anti-allergic principles of Petasites japonicus Maxim. Chemical and Pharmaceutical Bulletin, 31, 745-758.
24. Wuthrich, B. (1989). Epidemiology of the allergic diseases: Are they really on the increase? International Archives of Allergy and Applied Immunology, 90(Suppl. 1), 3-10.
25. Zhao, W., Oskeritzian, C.A., Pozez, A.L., & Schwartz, L.B. (2005). Cytokine production by skin-derived mast cells: Endogenous proteases are responsible for degradation of cytokines. Journal of Immunology, 175, 2635-2642.